SPI

SPI handeln
18.600,90 PKT +18,41 PKT +0,10 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 998750

ISIN CH0009987501


Analysen zu SPI-Werten

Datum Rating Analyst
06.12.16 UBS overweight Morgan Stanley
06.12.16 Roche overweight JP Morgan Chase & Co.
06.12.16 Swiss Re Neutral Goldman Sachs Group Inc.
05.12.16 UBS Hold Deutsche Bank AG
05.12.16 Swiss Re Neutral Goldman Sachs Group Inc.
05.12.16 Swiss Re Underperform Credit Suisse Group
05.12.16 Swiss Re kaufen DZ BANK
05.12.16 Swiss Re Neutral UBS AG
05.12.16 UBS buy HSBC
05.12.16 Swiss Re Hold S&P Capital IQ
02.12.16 UBS Neutral Credit Suisse Group
02.12.16 Nestlé buy Goldman Sachs Group Inc.
01.12.16 ABB (Asea Brown Boveri) Neutral Goldman Sachs Group Inc.
30.11.16 Roche buy Citigroup Corp.
30.11.16 Roche buy Deutsche Bank AG
30.11.16 Novartis Hold Deutsche Bank AG
30.11.16 Givaudan buy Deutsche Bank AG
30.11.16 Swiss Re Neutral Goldman Sachs Group Inc.
29.11.16 Swiss Re Hold Kepler Cheuvreux
29.11.16 Zurich Insurance Reduce Kepler Cheuvreux
29.11.16 Holcim Sell Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
29.11.16 Nestlé buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
29.11.16 Roche Strong Buy S&P Capital IQ
29.11.16 Swiss Re Underweight Morgan Stanley
29.11.16 Zurich Insurance buy HSBC
29.11.16 Holcim market-perform Bernstein Research
29.11.16 Roche overweight JP Morgan Chase & Co.
29.11.16 Holcim buy HSBC
28.11.16 Holcim Neutral UBS AG
28.11.16 Swiss Re Outperform Macquarie Research
27.11.16 Holcim Neutral JP Morgan Chase & Co.
27.11.16 Holcim Sell Société Générale Group S.A. (SG)
27.11.16 Holcim buy Deutsche Bank AG
27.11.16 Zurich Insurance Equal-Weight Morgan Stanley
27.11.16 Nestlé verkaufen Credit Suisse Group
27.11.16 Givaudan Underweight Barclays Capital
27.11.16 Givaudan Neutral Goldman Sachs Group Inc.
18.11.16 Zurich Insurance buy Baader Bank
18.11.16 Novartis overweight JP Morgan Chase & Co.
18.11.16 Swiss Re overweight JP Morgan Chase & Co.